AC2993 (exenatide)Potential Treatment for Type 2 Diabetes
Unique, potent glucose-lowering agent
- Active when glucose is high; inactive when glucose is low
- Restores more normal beta-cell response
- Potential to address the spectrum of type 2 diabetes
Additional possible upsides:
- Sustained release (LAR) formulation in Phase 2
- Improved weight management in type 2 diabetes
- Positive beta-cell effects